Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:HYPR NASDAQ:MBOT NASDAQ:SNWV NASDAQ:STRR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHYPRHyperfine$1.69+0.6%$1.23$0.53▼$2.22$164.57M1.42748,504 shs354,147 shsMBOTMicrobot Medical$2.13$2.41$1.60▼$4.67$143.05M1.061.57 million shs954,484 shsSNWVSanuwave Health$15.57-6.5%$19.68$15.35▼$46.58$143.16M1.3794,275 shs96,386 shsSTRRStar Equity$9.46+2.3%$9.74$8.26▼$11.99$34.29M0.432,859 shs1,444 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHYPRHyperfine-2.89%+1.20%+51.35%+52.73%+137.09%MBOTMicrobot Medical-2.74%+1.91%-6.99%+21.02%-15.14%SNWVSanuwave Health+4.59%+1.71%+0.60%-35.54%-47.38%STRRStar Equity+1.22%-1.44%-0.16%-4.18%+304.03%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHYPRHyperfine$1.69+0.6%$1.23$0.53▼$2.22$164.57M1.42748,504 shs354,147 shsMBOTMicrobot Medical$2.13$2.41$1.60▼$4.67$143.05M1.061.57 million shs954,484 shsSNWVSanuwave Health$15.57-6.5%$19.68$15.35▼$46.58$143.16M1.3794,275 shs96,386 shsSTRRStar Equity$9.46+2.3%$9.74$8.26▼$11.99$34.29M0.432,859 shs1,444 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHYPRHyperfine-2.89%+1.20%+51.35%+52.73%+137.09%MBOTMicrobot Medical-2.74%+1.91%-6.99%+21.02%-15.14%SNWVSanuwave Health+4.59%+1.71%+0.60%-35.54%-47.38%STRRStar Equity+1.22%-1.44%-0.16%-4.18%+304.03%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHYPRHyperfine 2.33Hold$1.59-6.07% DownsideMBOTMicrobot Medical 2.60Moderate Buy$7.50252.11% UpsideSNWVSanuwave Health 2.50Moderate Buy$51.00227.55% UpsideSTRRStar Equity 2.40Hold$16.5074.42% UpsideCurrent Analyst Ratings BreakdownLatest STRR, SNWV, HYPR, and MBOT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/6/2026STRRStar Equity Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/29/2026HYPRHyperfine BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$2.004/21/2026HYPRHyperfine Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/14/2026MBOTMicrobot Medical HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$12.004/10/2026MBOTMicrobot Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)3/30/2026SNWVSanuwave Health Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell3/30/2026SNWVSanuwave Health Roth MkmSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$53.00 ➝ $47.003/27/2026SNWVSanuwave Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D-) ➝ Hold (C-)3/23/2026STRRStar Equity Litchfield Hills ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$21.00 ➝ $28.003/19/2026HYPRHyperfine Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold3/19/2026HYPRHyperfine Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$2.00 ➝ $2.50(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHYPRHyperfine$11.40M14.52N/AN/A$0.42 per share4.02MBOTMicrobot MedicalN/AN/AN/AN/A$1.15 per shareN/ASNWVSanuwave Health$44.05M3.04$1.59 per share9.81$0.19 per share81.95STRRStar Equity$172.16M0.20$0.65 per share14.60$19.12 per share0.49Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHYPRHyperfine-$35.57M-$0.44N/AN/AN/A-262.29%-95.09%-71.11%5/12/2026 (Estimated)MBOTMicrobot Medical-$13.14M-$0.29N/AN/AN/AN/A-24.44%-23.12%5/13/2026 (Estimated)SNWVSanuwave Health$11.81M-$0.16N/A16.39N/A26.64%-141.56%34.53%5/8/2026 (Estimated)STRRStar Equity-$5.92M-$2.05N/A7.01N/A-3.44%-1.17%-0.73%5/12/2026 (Estimated)Latest STRR, SNWV, HYPR, and MBOT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026N/AMBOTMicrobot Medical-$0.08N/AN/AN/A$0.30 millionN/A5/12/2026Q1 2026HYPRHyperfine-$0.09N/AN/AN/A$3.54 millionN/A5/12/2026N/ASTRRStar Equity$0.05N/AN/AN/A$52.57 millionN/A5/8/2026Q1 2026SNWVSanuwave Health-$0.05N/AN/AN/A$9.65 millionN/A3/27/2026Q4 2025MBOTMicrobot Medical-$0.06-$0.04+$0.02-$0.04$0.11 millionN/A3/26/2026Q4 2025SNWVSanuwave Health$0.17$0.03-$0.14$0.6360$13.23 million$13.09 million3/18/2026Q4 2025HYPRHyperfine-$0.08-$0.06+$0.02-$0.06$5.30 million$5.29 million3/17/2026Q4 2025STRRStar Equity$0.13-$0.10-$0.23-$0.67$59.08 million$56.79 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthHYPRHyperfineN/AN/AN/AN/AN/AMBOTMicrobot MedicalN/AN/AN/AN/AN/ASNWVSanuwave HealthN/AN/AN/AN/AN/ASTRRStar EquityN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHYPRHyperfineN/A4.343.73MBOTMicrobot MedicalN/A23.3323.16SNWVSanuwave Health10.081.381.05STRRStar Equity0.092.101.86Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHYPRHyperfine15.03%MBOTMicrobot Medical16.30%SNWVSanuwave Health42.53%STRRStar Equity3.84%Insider OwnershipCompanyInsider OwnershipHYPRHyperfine26.33%MBOTMicrobot Medical4.74%SNWVSanuwave Health14.90%STRRStar Equity33.51%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHYPRHyperfine19097.96 million72.17 millionOptionableMBOTMicrobot Medical2067.16 million63.98 millionOptionableSNWVSanuwave Health408.60 million7.32 millionN/ASTRRStar Equity1,2003.71 million2.47 millionNot OptionableSTRR, SNWV, HYPR, and MBOT HeadlinesRecent News About These CompaniesStar Equity Holdings to Release First Quarter 2026 Financial Results on May 11May 6 at 4:15 PM | globenewswire.comStar Equity Holdings Announces Proposal to Acquire GEE Group for $0.30 per ShareMay 6 at 8:30 AM | globenewswire.comStar Equity Fund Calls on GEE Group to Change Egregious Executive Employment AgreementsApril 29, 2026 | globenewswire.comStar Equity Holdings, Inc.April 12, 2026 | edition.cnn.comInsider Selling: Star Equity (NASDAQ:STRR) CEO Sells 7,722 Shares of StockApril 3, 2026 | insidertrades.comStar Equity (NASDAQ:STRR) Director Louis Parks Acquires 1,500 SharesMarch 29, 2026 | insidertrades.comStar Equity Holdings (STRR) price target increased by 11.76% to 19.38March 27, 2026 | msn.comLooking for a Growth Stock? 3 Reasons Why Star Equity Holdings (STRR) is a Solid ChoiceMarch 25, 2026 | zacks.comWall Street Analysts Believe Star Equity Holdings (STRR) Could Rally 92.31%: Here's is How to TradeMarch 25, 2026 | zacks.comStar Equity Holdings, Inc.: Star Equity Holdings Reports 2025 Fourth Quarter and Full-Year ResultsMarch 21, 2026 | finanznachrichten.deStar Equity Holdings Inc (STRR) Q4 2025 Earnings Call Highlights: Impressive Revenue and Profit ...March 19, 2026 | uk.finance.yahoo.comStar Equity outlines 2026 growth plans with Building Solutions and Energy Services poised for recoveryMarch 18, 2026 | seekingalpha.comStar Equity Holdings, Inc. (STRR) Q4 2025 Earnings Call TranscriptMarch 18, 2026 | seekingalpha.comStar Equity Holdings: Q4 Earnings SnapshotMarch 17, 2026 | myjournalcourier.comMStar Equity Holdings (STRR) Reports Q4 Loss, Lags Revenue EstimatesMarch 17, 2026 | zacks.comStar Equity Holdings Reports 2025 Fourth Quarter and Full-Year ResultsMarch 17, 2026 | globenewswire.comStar Equity Holdings to Release Fourth Quarter 2025 Financial Results on March 17March 13, 2026 | globenewswire.comStar Equity Holdings (STRR) to Report Q4 Results: Wall Street Expects Earnings GrowthMarch 6, 2026 | zacks.comStar Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred StockFebruary 13, 2026 | globenewswire.comGEE Group Addresses Star Equity’s Public Commentary Regarding Indication of InterestJanuary 31, 2026 | palmbeachpost.comPNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSTRR, SNWV, HYPR, and MBOT Company DescriptionsHyperfine NASDAQ:HYPR$1.69 +0.01 (+0.60%) Closing price 04:00 PM EasternExtended Trading$1.71 +0.02 (+1.12%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.Microbot Medical NASDAQ:MBOT$2.13 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$2.14 +0.01 (+0.47%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.Sanuwave Health NASDAQ:SNWV$15.57 -1.08 (-6.49%) Closing price 04:00 PM EasternExtended Trading$15.66 +0.09 (+0.58%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.Star Equity NASDAQ:STRR$9.38 +0.13 (+1.41%) As of 04:00 PM Eastern This is a fair market value price provided by Massive. Learn more.Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SoundHound’s Bottom Is In—Inflection and 50% Upside Ahead? Rocket Lab Posts Record Q1 Revenue, Raises Q2 Guidance Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus AppLovin Pops After Earnings With Growth Catalysts in Sight Dutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality Check The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Why Lam Research Still Looks Like a Buy After a 300% Rally Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
